Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis

Figure 1

Juvenile idiopathic arthritis and related disorders in the different patient groups studied. CO, children not treated with naproxen (controls); CRMO, chronic recurrent multifocal osteomyelitis; JIA-EOPA: euvenile idiopathic arthritis, early-onset pauciarticular subtype; PP+, children treated with naproxen who developed pseudoporphyria; PP-, children treated with naproxen who did not develop pseudoporphyria.

Back to article page